CoChat

Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients

Cruzado, Juan Antonio, López-Santiago, Sonia, Martínez-Marín, Virginia, José-Moreno, Gema, Custodio, Ana Belén, Feliu, Jaime · 2014 · Supportive Care in Cancer
Cited by 79

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00520-014-2147-x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 39

  1. Argyriou AA, Assimakopoulos K, Iconomou G et al (2011) Either called “chemobrain” or “chemofog”, the long-term chemotherapy-induced cognitive decline in cancer survivors is real. J Pain Symptom Manage 41:126–139. doi: 10.1016/j.jpainsymman.2010.04.021 · DOI · Paper page
  2. Janelsins MC, Kohli S, Mohile SG et al (2011) An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol 20(38):431–438. doi: 10.1053/j.seminoncol.2011.03.014 · DOI · Paper page
  3. Ahles TA, Saykin AJ, Furstenberg CT et al (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20:485–493. doi: 10.1200/JCO.20.2.485 · doi:10.1200/jco.20.2.485 · Paper page
  4. Wefel JS, Lenzi R, Theriault RL et al (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100:2292–2299. doi: 10.1002/cncr.20272 · DOI · Paper page
  5. Quesnel C, Savard J, Ivers H (2009) Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat 116:113–123. doi: 10.1007/s10549-008-0211-2 · DOI · Paper page
  6. Wefel JS, Saleeba AK, Buzdar AU, Meyers CA (2010) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116:3348–3356. doi: 10.1002/cncr.25098 · DOI · Paper page
  7. Phillips KM, Jim HS, Small BJ et al (2012) Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls. Cancer 118:1925–1932. doi: 10.1002/cncr.26432 · DOI · Paper page
  8. Koppelmans V, Breteler MM, Boogerd W et al (2012) Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol 30:1080–1086. doi: 10.1200/JCO.2011.37.0189 · DOI · Paper page
  9. Vardy J, Rourke S, Tannock IF (2007) Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 25:2455–2463. doi: 10.1200/JCO.2006.08.1604 · DOI · Paper page
  10. Wefel JS, Schagen SB (2012) Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep 12:267–275. doi: 10.1007/s11910-012-0264-9 · DOI · Paper page
  11. Jansen CE, Miaskowski C, Dodd M et al (2005) A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 104:2222–2223. doi: 10.1002/cncr.21469 · DOI · Paper page
  12. Falleti MG, Sanfilippo A, Maruff P et al (2005) The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn 59:60–70. doi: 10.1016/j.bandc.2005.05.001 · DOI · Paper page
  13. Stewart A, Bielajew C, Collins B et al (2006) (2006). A metaanalysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol 20:76–89. doi: 10.1080/138540491005875 · DOI · Paper page
  14. Jim HS, Phillips KM, Chait S et al (2012) Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol 30:3578–3587. doi: 10.1200/JCO.2011.39.5640 · DOI · Paper page
  15. Boykoff N, Moieni M, Subramanian SK (2009) (2009). Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Surviv 3:223–232. doi: 10.1007/s11764-009-0098-x · DOI · Paper page
  16. Ahles TA, Saykin AJ, McDonald BC et al (2010) Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 28:4434–4440. doi: 10.1200/JCO.2009.27.0827 · DOI · Paper page
  17. Schagen SB, Muller MJ, Boogerd W et al (2002) Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 13:1387–1397. doi: 10.1093/annonc/mdf241 · DOI · Paper page
  18. Vearncombe KJ, Rolfe M, Wright M et al (2009) Predictors of cognitive decline after chemotherapy in breast cancer patients. J Int Neuropsychol Soc 15:951–962. doi: 10.1017/S1355617709990567 · DOI · Paper page
  19. Jenkins V, Shilling V, Deutsch G et al (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828–834. doi: 10.1038/sj.bjc.6603029 · DOI · Paper page
  20. Hermelink K, Untch M, Lux MP et al (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 109:1905–1913. doi: 10.1002/cncr.22610 · DOI · Paper page
  21. Jim HS, Donovan KA, Small BJ et al (2009) Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer 115:776–783. doi: 10.1002/cncr.24192 · doi:10.1002/cncr.24051
  22. Wefel J, Vardy J, Ahles T, Schagen S (2011) International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12:703–708. doi: 10.1016/S1470-2045(10)70294-1 · DOI · Paper page
  23. Peña-Casanova J (2005) Test de Barcelona-Revisado. Programa Integrado de Exploración Neuropsicológica. Elsevier- Masson, Barcelona
  24. Reitan RM, Olfson D (1985) The Halstead–Reitan Neuropsychological Test Battery: therapy and clinical interpretation. Neuropsychological Press, Tucson
  25. Fayers P, Bottomley A, EORTC Quality of Life Group; Quality of Life Unit (2002) Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer 38(Suppl 4):S125–S133. doi: 10.1016/S0959-8049(01)00448-8 · DOI · Paper page
  26. Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x · DOI · Paper page
  27. Mendoza TR, Wang XS, Cleeland CS et al (1999) The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85:1186–1196. doi: 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N · DOI
  28. Crawford JR, Garthwaite PH, Gault CB (2007) Estimating the percentage of the population with abnormally low scores (or abnormally large score differences) on standardized neuropsychological test batteries: a generic method with applications. Neuropsychology 21:419–430. doi: 10.1037/0894-4105.21.4.419 · DOI · Paper page
  29. Chelune GJ, Naugle RI, Luders H et al (1993) Individual change after epilepsy surgery: practice effects and base-rate information. Neuropsychology 7:41–52. doi: 10.1037//0894-4105.7.1.41 · doi:10.1037/0894-4105.7.1.41 · Paper page
  30. Quintana M, Peña-Casanova J, Sánchez-Benavides G et al (2011) Spanish multicenter normative studies (Neuronorma project): norms for the abbreviated Barcelona test. Arch Clin Neuropsychol 26:144–157. doi: 10.1093/arclin/acq098 · DOI
  31. García A, Fernández M, Blesa R et al (2012) Using artificial neural networks in clinical neuropsychology: high performance in mild cognitive impairment and Alzheimer’s disease. Exp Neuropsychol 34:195–208. doi: 10.1080/13803395.2011.630651 · DOI
  32. Molinuevo JL, Gómez-Anson B, Monte GC et al (2011) Neuropsychological profile of prodromal Alzheimer’s disease (Prd-AD) and their radiological correlates. Arch Gerontol Geriatr 52:190–196. doi: 10.1016/j.archger.2010.03.016 · DOI
  33. Lezak MD, Howieson DB, Bigler ED et al (2012) Neuropsychological assessment, 5th edn. Oxford University Press, New York
  34. Wefel JS, Vidrine DJ, Veramonti TL et al (2011) Cognitive impairment in men with testicular cancer prior to adjuvant therapy. Cancer 117:190–196. doi: 10.1002/cncr.25298 · DOI
  35. Benveniste H, Zhang S, Reinsel RA et al (2012) (2012). Brain metabolomic profiles of lung cancer patients prior to treatment characterized by proton magnetic resonance spectroscopy. Int J Clin Exp Med 5:154–164
  36. Andreis F, Ferri M, Mazzocchi M et al (2013) (2013). Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A pilot study. Support Care Cancer 21:583–590. doi: 10.1007/s00520-012-1560-2 · doi:10.1007/s00520-012-1560-2
  37. Mancuso A, Migliorino M, De Santis S et al (2006) Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Ann Oncol 17:146–150. doi: 10.1093/annonc/mdj038 · DOI
  38. Sharpe MJ, Fardell JE, Vardy J, Johnston IN (2012) The chemotherapy agent oxaliplatin impairs the renewal of fear to an extinguished conditioned stimulus in rats. Behav Brain Res 227:295–299. doi: 10.1016/j.bbr.2011.11.005 · DOI
  39. Fardell JE, Vardy J, Shah JD, Johnston IN (2012) Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity. Psychophar-macology (Berl) 220:183–193. doi: 10.1007/s00213-011-2466-2 · DOI

Cited by

See all 79

Metadata

Authors
Cruzado, J. A., López-Santiago, S., Martínez-Marín, V., José-Moreno, G., Custodio, A. B., & Feliu, J.
Venue
Supportive Care in Cancer
Published
2014-02-18
Volume
22
Issue
7
Pages
1815-1823
ISSN
  • 0941-4355
  • 1433-7339
Cited by
79
References
2
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients. https://app.cochat.ai/papers/10.1007/s00520-014-2147-x
The paper
Cruzado, J. A., López-Santiago, S., Martínez-Marín, V., José-Moreno, G., Custodio, A. B., & Feliu, J. (2014). Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients. Supportive Care in Cancer. https://doi.org/10.1007/s00520-014-2147-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.